Article
Safety and Efficacy Conerns in the Use of Intravitreal Anti-VEGF Therapy (Sponsored)
This supplement to Ophthalmology Times is sponsored by CME Matters, LLC, and supported by an unrestricted grant from Regeneron Pharmaceuticals, Inc.
Safety and Efficacy Conerns in the
Use of Intravitreal Anti-VEGF Therapy
The Historical Perspective on
Efficacy and Systemic Safety
This supplement to Ophthalmology Times is sponsored by CME Matters, LLC, and supported by an unrestricted grant from Regeneron Pharmaceuticals, Inc.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
